EQL Pharma AB (publ) reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was SEK 70.21 million compared to SEK 80.19 million a year ago. Net income was SEK 6.51 million compared to SEK 11.95 million a year ago. Earnings per share was SEK 0.22 compared to SEK 0.40 a year ago.

For the nine months, sales was SEK 186.03 million compared to SEK 199.58 million a year ago. Net income was SEK 18.01 million compared to SEK 26.8 million a year ago. Earnings per share was SEK 0.60 compared to SEK 0.90 a year ago.